# This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

> **NCT00548262** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 54 (actual)

## Conditions studied

- Candidemia
- Invasive Candidiasis

## Interventions

- **DRUG:** Anidulafungin
- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00548262
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548262, "This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00548262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*